Baqsimi (glucagon), first non-injectable treatment for severe low blood sugar levels
12 Novembre 2019
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Baqsimi (glucagon), the first treatment for severe hypoglycaemia (low blood sugar
